Unicycive Therapeutics Financial Overview
Unicycive Therapeutics's market cap is currently $119.49M. The company's EPS TTM is $-0.33; its P/E ratio is -1.71; Unicycive Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.43. See an overview of income statement, balance sheet, and cash flow financials.
